Newsletter Archive

1. 01.20.21 -- Pitching And Fundraising In The New Norm 1/20/2021
   01/20/21 Life Science Leader Newsletter
2. 01.20.21 -- How High-Throughput Formulation Development Impacts Early Screening Studies 1/20/2021
   01/20/21 Life Science Leader Newsletter
3. 01.19.21 -- Overcoming Cell And Gene Commercialization Challenges 1/19/2021
   01/19/21 Life Science Leader Newsletter
4. 01.18.21 -- What I Learned Running A Biotech During The Pandemic 1/18/2021
   01/18/21 Life Science Leader Newsletter
5. 01.18.21 -- How To Create A Connected mAb Perfusion Process 1/18/2021
   01/18/21 Life Science Leader Newsletter
6. 01.15.21 -- FDA FY2020 Drug Inspection Observations And Trends 1/15/2021
   01/15/21 Life Science Leader Newsletter
7. 01.15.21 -- How To Navigate Regulatory Frameworks For Gene Therapy Development 1/15/2021
   01/15/21 Life Science Leader Newsletter
8. 01.14.21 -- Reducing Risk In Transferring Vaccine Production 1/14/2021
   01/14/21 Life Science Leader Newsletter
9. 01.13.21 -- Going Public In Mid-Pandemic 1/13/2021
   01/13/21 Life Science Leader Newsletter
10. 01.13.21 -- New Year, New Podcast Episodes: Clinical Trials During A Pandemic; Gene Therapies At Scale 1/13/2021
    01/13/21 Life Science Leader Newsletter